HSP27 and Atherogenic Index of the Plasma - heralding cardiovascular complications inIndian diabetic subjects
Journal Title: Journal of Endocrinology and Diabetes - Year 2017, Vol 4, Issue 5
Abstract
Aim: To evaluate the importance of Heat shock protein 27 (HSP27) and Atherogenic Index of the Plasma (AIP) in diabetic subjects, as indicators of cardiovascular disease progression in diabetic subjects. Materials and Methods: 144 subjects were recruited in 4 different groups as follows: Group A1- diabetic > 5 years and hypertensive (N = 55), Group A2 – diabetic < 2 years (N = 28), Group B1 – hypertensive (N = 31) and Group B2 – healthy controls (N = 30). Anthropometric measurements were made and blood biochemistry profiles were established using standard protocols. AIP was calculated as Log (Triglycerides / HDL cholesterol),while HSP27 was measured using ELISA. Results: HSP27 varied significantly across the groups (one-way ANOVA, (F (3) = 4.95, p = 0.003). We saw significant increase in HSP27 levels between Groups A1 and B2, Groups A2 and B2, Groups A1 and B1, and Groups A2 and B1 (p= 0.001, 0.025, 0.003 and 0.043 respectively). AIP scores increased across the groups, although not significantly (one-way ANOVA, F (3) = 1.8, p = 0.15).The frequency of high risk AIP scores were more in Groups A1 and A2 as compared to the controls. HSP27 was negatively correlated with the AIP score, (Pearson’s coefficient = -0.173, p = 0.039). Two models of multivariate linear regression revealed that HSP27 and post prandial blood sugar (PPBS) were significant risk factors of AIP; F (5, 138) = 3.069, p = 0.012, R2 = 0.10. (Model 1, t = -2.591, p = 0.011; 95% CI = -0.269 to -0.036 and model 2, t = -2.332, p = 0.021; 95% CI = -0.256 to -0.021). Conclusion: Serum HSP27 and AIP increase in diabetic subjects with or without hypertension. The risk of cardiovascular complications can be monitored using HSP27.
Authors and Affiliations
Sudha S. Deo, Prashant S. Ratnaparkhi, Namrata B. Kulkarni, Meghana U. Ganu, Sanjay G. Godbole
Keywords
Related Articles
- EP ID EP334005
- DOI 10.15226/2374-6890/4/5/00189
- Views 85
- Downloads 0
Development of Assessment and Screening Tool to Assist with Prevention and Identification of Charcot Foot in Type 2 Diabetics
The DNP project is intended to improve patient care with the use of an assessment and screening tool and algorithm to aid in early identification of Charcot foot in the type 2 diabetic patient populations. The project in...
Prevalence of Dyslipidemia and The Associated Factors Among Type 2 Diabetes Patients in Turbo Sub-County kenya
Background: A large number of deaths worldwide are attributed to non-communicable diseases (NCDs). Diabetes, an important NCD, contributes to this large mortality mainly through cardiovascular complications. Cardiovascul...
Thyroid-Induced Toxicity of Check-Point Inhibitors Immunotherapy in the Treatment of Advanced Non-Small Cell Lung Cancer
Immunotherapy represents a new strategy in the fight against cancer diseases based on the key role that immune system plays to identify and destroy foreign or abnormal cells in the body, including tumor cells. Nowadays,...
Observational Study of the Tunisian Diabetic Patients' Profile during the Fasting of the Holy Month of Ramadan
Aims: To analyze the profile of patients with Type 1 Diabete Mellitus (T1DM) and Type 2 Diabetes Mellitus (T2DM) fasting during Ramadan. Methods: Descriptive observational epidemiological study in T1DM and T2DM diabetes...
New insights for the polypharmacy use in elderly with Diabetes-An update about effect of education level
Aim: To assess the effect of education diabetics in polypharmacy use and correlate with the scores of tests Medtake (MT), Diabetes Complications (DC) Morisky-Green (MGT) and pharmacotherapy complexity (PC). Methods: We...